Test Price
2,800 AED✅ Home Collection Available
ZNF41 Gene X-Linked Intellectual Disability Type 89 Genetic Test in UAE
Executive Summary & Core Metrics
Premium Clinical Genetics Service – DNA Labs UAE
- Test Price: 2,800 AED – Full gene sequencing with clinical interpretation.
- Diagnostic Precision: >99.9% analytical sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited NGS pipeline.
- Complimentary Home Collection: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Integrated Post-Test Support: Telephonic consultation with a DHA-licensed Consultant Medical Geneticist to contextualize results and guide family management.
- Direct Insurance Facilitation: Rapid pre-authorization and billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced molecular diagnostic assay utilizes Next Generation Sequencing (NGS) to comprehensively analyze the entire coding region and splice sites of the ZNF41 gene. The test is specifically designed to detect pathogenic variants associated with X-linked intellectual disability type 89 (XLID89), enabling accurate molecular confirmation, targeted clinical management, and precise recurrence risk counseling for affected families in the UAE.
| Feature | DNA Labs UAE Test | Closest Alternative |
|---|---|---|
| Precision & Scope | Full gene NGS >99.9% analytical sensitivity | Single exon MLPA or targeted Sanger (limited) |
| Methodology | Next Generation Sequencing (Illumina® Platform) | Sanger sequencing of select exons |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Specimen Logistics | VIP Mobile Phlebotomy & Cold-Chain (8 AM – 11 PM) | Clinic-only draw, limited hours |
| Insurance Support | Direct billing verification via WhatsApp | Manual patient reimbursement |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant in Medical Genetics, I emphasize that a ZNF41 variant must always be correlated with the complete clinical phenotype and comprehensive family history. A negative sequencing report does not exclude other genetic etiologies of intellectual disability and should prompt consideration of broader genomic testing, such as whole exome sequencing. This test is a powerful diagnostic adjunct but must be interpreted within a multidisciplinary framework that includes neurology, developmental pediatrics, and genetic counseling. Families are advised never to discontinue prescribed therapies without explicit consultation with their managing physician.”
Advisory Notice: Medication & Test Preparation
⚠️ Important Medication Safety Information
Do not discontinue any prescribed antiepileptic, neuroleptic, or behavioral medication prior to or during the genetic testing process unless explicitly directed by your primary neurologist or managing physician. Abrupt cessation of these medications can lead to severe withdrawal symptoms or seizure recurrence.
Exclusion Criteria & Emergency Red Flags
- Confirmed diagnosis of a common aneuploidy (e.g., Down syndrome) that sufficiently explains the intellectual disability phenotype.
- Active acute febrile illness or severe systemic infection at the time of scheduled blood collection.
- Emergency Contraindication: If the patient presents with acute neurological deterioration, status epilepticus, or loss of consciousness, seek immediate emergency medical care before proceeding with elective outpatient genetic testing.
- Inadequate or improperly documented informed consent from the legal guardian, as mandated by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the purpose of the ZNF41 gene test?
This test identifies pathogenic variants in the ZNF41 gene to confirm a molecular diagnosis of X-linked intellectual disability type 89 (XLID89). This confirmation enables tailored early intervention strategies, precise genetic counseling for the family, and accurate recurrence risk estimation for future pregnancies.
2. How is the sample collected, and is home service available in the UAE?
Sample collection requires a standard peripheral whole blood draw (3-5 mL in an EDTA tube) or a dried blood spot on an FTA card. A DHA-licensed phlebotomist will visit your home, office, or hotel across the UAE between 8 AM and 11 PM. The specimen is transported to our ISO 9001:2015 accredited laboratory via a temperature-controlled cold chain to ensure genomic integrity.
3. What do the results mean, and what are the next steps?
Positive Result: Confirms the genetic cause of intellectual disability, guiding a personalized care plan and family counseling. Variant of Uncertain Significance (VUS): Requires periodic re-analysis and segregation studies. Negative Result: Does not rule out a genetic cause and may necessitate broader genomic testing such as whole exome sequencing. All results must be discussed with your referring physician and our Consultant Medical Geneticist.
4. What is the cost and turnaround time for this test?
The total price for the ZNF41 gene sequencing test is 2,800 AED. The standard turnaround time from sample receipt at our Dubai Healthcare City laboratory is 3 to 4 weeks. Direct insurance billing and pre-authorization support is available via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Privacy Framework: DNA Labs UAE strictly adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures and patient consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility operates under DHA Facility License Number: 1143, and our quality management system is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | ZNF41 Gene X-Linked Intellectual Disability Type 89 Sequencing |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL EDTA tube) or FTA Card Dried Blood Spot |
| Methodology Used | Next Generation Sequencing (NGS) – Illumina® Platform |
| ICD-10-CM Code | F79 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians